Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Weinreb

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Blood|October 10, 2009
Mesenchymal gaucho homing on the rangeNeal J Weinreb
Expert Opinion on Pharmacotherapy|July 17, 2008
Imiglucerase and its use for the treatment of Gaucher's diseaseNeal J Weinreb
Best Practice & Research. Clinical Haematology|December 13, 2023
The international cooperative Gaucher group (ICCG) Gaucher registryNeal J Weinreb
Pediatric Endocrinology Reviews : PER|January 2, 2014
Oral small molecule therapy for lysosomal storage diseasesNeal J Weinreb
Expert Review of Endocrinology & Metabolism|February 13, 2019
Bone disease in patients with Gaucher diseaseBarry E Rosenbloom, Neal J Weinreb
Continuum (Minneapolis, Minn.)|July 20, 2012
Patient management problem-preferred responsesDeborah S Barbouth, Neal J Weinreb
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease: a comprehensive reviewBarry E Rosenbloom, Neal J Weinreb
Critical Reviews in Oncogenesis|March 21, 2013
Causes of death due to hematological and non-hematological cancers in 57 US patients with type 1 Gaucher Disease who were never treated with enzyme replacement therapyNeal J Weinreb, Robert E Lee
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
The attenuated/late onset lysosomal storage disorders: Therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry diseaseCarla E M Hollak, Neal J Weinreb
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Disease state awareness in Gaucher disease: a Q&A expert roundtable discussionPramod K Mistry, Joel A Weinthal, Neal J Weinreb
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood|October 10, 2009
Mesenchymal gaucho homing on the rangeNeal J Weinreb
Expert Opinion on Pharmacotherapy|July 17, 2008
Imiglucerase and its use for the treatment of Gaucher's diseaseNeal J Weinreb
Best Practice & Research. Clinical Haematology|December 13, 2023
The international cooperative Gaucher group (ICCG) Gaucher registryNeal J Weinreb
Pediatric Endocrinology Reviews : PER|January 2, 2014
Oral small molecule therapy for lysosomal storage diseasesNeal J Weinreb
Expert Review of Endocrinology & Metabolism|February 13, 2019
Bone disease in patients with Gaucher diseaseBarry E Rosenbloom, Neal J Weinreb
Continuum (Minneapolis, Minn.)|July 20, 2012
Patient management problem-preferred responsesDeborah S Barbouth, Neal J Weinreb
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease: a comprehensive reviewBarry E Rosenbloom, Neal J Weinreb
Critical Reviews in Oncogenesis|March 21, 2013
Causes of death due to hematological and non-hematological cancers in 57 US patients with type 1 Gaucher Disease who were never treated with enzyme replacement therapyNeal J Weinreb, Robert E Lee
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
The attenuated/late onset lysosomal storage disorders: Therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry diseaseCarla E M Hollak, Neal J Weinreb
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Disease state awareness in Gaucher disease: a Q&A expert roundtable discussionPramod K Mistry, Joel A Weinthal, Neal J Weinreb
Pageof 5